Barely Significant
← all excerpts

Nimotuzumab enhances temozolomide-induced growth suppression of glioma cells expressing mutant EGFR in vivo.

Cancer Med · 2016 · PMC4799951 · PMID 26778701

Europe PMCDOI
1
hedged sentence
0.0580
closest p · 1.2× alpha
0.0580
boldest claim

The sentences

did not reach statistical significanceP = 0.058so close (0.05 < p ≤ 0.1)
In U87MG.wtEGFR tumors, a weaker tumor suppression was observed with NT combination treatment over TMZ alone, and this suppression did not reach statistical significance ( P = 0.058) (Fig. 3 B).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.